Literature DB >> 10420069

Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.

M L Bots1, M M Breteler, F van Kooten, F Haverkate, P Meijer, P J Koudstaal, D E Grobbee, C Kluft.   

Abstract

We performed a cross-sectional case-control study among 277 subjects with dementia and 298 control subjects drawn from participants of the Rotterdam Study, a population-based cohort study among subjects aged 55 years or over, and from participants of the Rotterdam Stroke Databank, a hospital-based stroke registry, with the objective to evaluate the association of indicators of coagulability, fibrinogen, prothrombin fragments 1+2, thrombin-antithrombin complex (TAT), and indicators of fibrinolysis, plasmin-inhibitor complex, D-dimer and tissue-type plasminogen activator (t-PA) with dementia. Increased levels of TAT, D-dimer and t-PA activity were associated with an increased risk of dementia. Additional stratified analyses indicated that an increased TAT level was the primary factor related to dementia. The present study provides evidence that predominantly increased thrombin generation is associated with dementia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10420069     DOI: 10.1159/000022433

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  9 in total

Review 1.  Blood-based biomarkers of Alzheimer's disease: challenging but feasible.

Authors:  Madhav Thambisetty; Simon Lovestone
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

2.  Association between cognition and gene polymorphisms involved in thrombosis and haemostasis.

Authors:  Terence J Quinn; Jahad Alghamdi; Sandosh Padmanabhan; David J Porteous; Blair H Smith; Lynne Hocking; Ian J Deary; John Gallacher; Martina Messow; David J Stott
Journal:  Age (Dordr)       Date:  2015-08-01

3.  Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease.

Authors:  Annika Ohrfelt; Ulf Andreasson; Adam Simon; Henrik Zetterberg; Ake Edman; William Potter; Daniel Holder; Viswanath Devanarayan; Jeffrey Seeburger; A David Smith; Kaj Blennow; Anders Wallin
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-01-14

4.  Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?

Authors:  Ramit Ravona-Springer; Michael Davidson; Shlomo Noy
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

5.  Alzheimer's disease: a clinical practice-oriented review.

Authors:  Luísa Alves; Ana Sofia A Correia; Rita Miguel; Paulo Alegria; Paulo Bugalho
Journal:  Front Neurol       Date:  2012-04-20       Impact factor: 4.003

Review 6.  Vascular Dementia and Crosstalk Between the Complement and Coagulation Systems.

Authors:  Milad Mossanen Parsi; Cédric Duval; Robert A S Ariëns
Journal:  Front Cardiovasc Med       Date:  2021-12-23

Review 7.  A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.

Authors:  Douglas B Kell; Gert Jacobus Laubscher; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

8.  Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study.

Authors:  Soo Chan Carusone; Marek Smieja; William Molloy; Charlie H Goldsmith; Jim Mahony; Max Chernesky; Judy Gnarpe; Tim Standish; Stephanie Smith; Mark Loeb
Journal:  BMC Neurol       Date:  2004-10-12       Impact factor: 2.474

9.  Deficiency of tPA Exacerbates White Matter Damage, Neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice.

Authors:  Peng Yu; Poornima Venkat; Michael Chopp; Alex Zacharek; Yi Shen; Linlin Liang; Julie Landschoot-Ward; Zhongwu Liu; Rongcai Jiang; Jieli Chen
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.